LONG-TERM EFFECT OF OPICAPONE IN PARKINSON&#39;S PATIENTS WITHOUT MOTOR COMPLICATIONS: 1.5-YEAR EPSILON STUDY FINDINGS

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

https://cslide.ctimeetingtech.com/adpd26/attendee/confcal/show/session/127

Helena C. Brigas; Joaquim J. Ferreira; Olivier Rascol; Fabrizio Stocchi; Angelo Antonini; Joana Moreira; José-Francisco Rocha; Miguel M. Fonseca; Joerg Holenz; Werner Poewe

Jan 10, 2026